Correlation Between Anebulo Pharmaceuticals and Cingulate Warrants
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Cingulate Warrants at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Cingulate Warrants into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Cingulate Warrants, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Cingulate Warrants and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Cingulate Warrants. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Cingulate Warrants.
Diversification Opportunities for Anebulo Pharmaceuticals and Cingulate Warrants
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Anebulo and Cingulate is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Cingulate Warrants in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate Warrants and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Cingulate Warrants. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate Warrants has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Cingulate Warrants go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Cingulate Warrants
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Cingulate Warrants. But the stock apears to be less risky and, when comparing its historical volatility, Anebulo Pharmaceuticals is 1.78 times less risky than Cingulate Warrants. The stock trades about -0.03 of its potential returns per unit of risk. The Cingulate Warrants is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 6.75 in Cingulate Warrants on September 12, 2024 and sell it today you would lose (3.38) from holding Cingulate Warrants or give up 50.07% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 98.44% |
Values | Daily Returns |
Anebulo Pharmaceuticals vs. Cingulate Warrants
Performance |
Timeline |
Anebulo Pharmaceuticals |
Cingulate Warrants |
Anebulo Pharmaceuticals and Cingulate Warrants Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Anebulo Pharmaceuticals and Cingulate Warrants
The main advantage of trading using opposite Anebulo Pharmaceuticals and Cingulate Warrants positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Cingulate Warrants can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate Warrants will offset losses from the drop in Cingulate Warrants' long position.Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Cingulate Warrants vs. Puma Biotechnology | Cingulate Warrants vs. Iovance Biotherapeutics | Cingulate Warrants vs. Sarepta Therapeutics | Cingulate Warrants vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |